Copayment Reductions Generate Greater Medication Adherence In Targeted Patients
- 1 November 2010
- journal article
- Published by Health Affairs (Project Hope) in Health Affairs
- Vol. 29 (11), 2002-2008
- https://doi.org/10.1377/hlthaff.2010.0571
Abstract
A large value-based insurance design program offered by Blue Cross Blue Shield of North Carolina eliminated generic medication copayments and reduced copayments for brand-name medications. Our study showed that the program improved adherence to medications for diabetes, hypertension, hyperlipidemia, and congestive heart failure. We found that adherence improved for enrollees, ranging from a gain of 3.8 percentage points for patients with diabetes to 1.5 percentage points for those taking calcium-channel blockers, when compared to others whose employers did not offer a similar program. An examination of longer-term adherence and trends in health care spending is still needed to provide a compelling evidence base for value-based insurance design.Keywords
This publication has 23 references indexed in Scilit:
- Evidence That Value-Based Insurance Can Be EffectiveHealth Affairs, 2010
- Impact of a Prescription Copayment Increase on Lipid-Lowering Medication Adherence in VeteransCirculation, 2009
- A test of financial incentives to improve warfarin adherenceBMC Health Services Research, 2008
- Interventions designed to improve the quality and efficiency of medication use in managed care: A critical review of the literature – 2001–2007BMC Health Services Research, 2008
- Cost-Effectiveness of Providing Full Drug Coverage to Increase Medication Adherence in Post-Myocardial Infarction Medicare BeneficiariesCirculation, 2008
- A Refill Adherence Algorithm for Multiple Short Intervals to Estimate Refill Compliance (ReComp)Medical Care, 2007
- What do we get for our money? Cost‐effectiveness of adding contingency managementAddiction, 2007
- Pay Enough or Don't Pay at All*The Quarterly Journal of Economics, 2000
- Combining Propensity Score Matching with Additional Adjustments for Prognostic CovariatesJournal of the American Statistical Association, 2000
- The demand for prescription drugs as a function of cost-sharingSocial Science & Medicine (1982), 1985